Absci Corporation (ABSI) vs Zenas BioPharma, Inc. (ZBIO)
A side-by-side comparison of Absci Corporation and Zenas BioPharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABSI
Absci Corporation
$10.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZBIO
Zenas BioPharma, Inc.
$26.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ABSI vs ZBIO
growth of $100 · dividends reinvested · last 2yABSI +199.5% (+73.1%/yr)ZBIO +54.9% (+24.4%/yr)ABSI compounded faster over this window
ABSI ZBIO
ABSI vs ZBIO: by the numbers
- •ABSI is the larger company ($1.74B vs $1.70B market cap).
- •Both run net losses; ABSI's is the smaller (-7756.37% vs -48438.40% net margin).
Metrics side by side
Valuation
| Metric | ABSI | ZBIO |
|---|---|---|
| P/S ratio | 1114.50 | 1700.81 |
| P/B ratio | 7.07 | 6.88 |
Profitability
| Metric | ABSI | ZBIO |
|---|---|---|
| Gross margin | -319.36% | 100.00% |
| Operating margin | -4454.21% | -2113.85% |
| Net margin | -7756.37% | -48438.40% |
| ROE | -49.19% | -196.03% |
| ROIC | -52.66% | -74.69% |
Growth (annualized)
| Metric | ABSI | ZBIO |
|---|---|---|
| Revenue CAGR (5Y) | -22.08% | N/A |
| Total return CAGR (5Y) | 0.89% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.